[1] |
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138: 271-281.
|
[2] |
Ostchega Y, Paulose-Ram R, Dillon CF, et al. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999—2004[J]. J Am Geriatr Soc, 2007, 55(4): 583-589.
|
[3] |
Lazzarini PA, Hurn SE, Fernando ME, et al. Prevalence of foot disease and risk factors in general inpatient populations: A systematic review and Meta-analysis[J]. BMJ Open, 2015, 5(11): e008544.
|
[4] |
Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe Baseline results from the Eurodiale study[J]. Diabetologia, 2007, 50(1): 18-25.
|
[5] |
Sr MJL, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)[J]. J Vasc Surg, 2014, 59(1): 220-234.
|
[6] |
崔公让. 糖尿病肢体动脉闭塞症诊断及疗效标准(草案)[J]. 中西医结合心脑血管病杂志, 2004, 2(6): 352.
|
[7] |
姚雪莉. 硫氧还蛋白非酶糖化修饰在糖尿病大鼠心肌缺血/再灌注损伤敏感性增加中的作用[D]. 太原:山西医科大学, 2014.
|
[8] |
Giannini C, Mohn A, Chiarelli F, et al. Macrovascular angiopathy in children and adolescents with type 1 diabetes[J]. Diabetes Metab Res Rev, 2011, 27(5): 436-460.
|
[9] |
Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications[J]. J Clin Endocrinol Metab, 2009, 94(9): 3171-3182.
|
[10] |
Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I[J]. Circulation, 2003, 108(12): 1527-1532.
|
[11] |
Lüscher TF, Creager MA, Beckman JA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II[J]. Circulation, 2003, 108(13): 1655-1661.
|
[12] |
Faglia E, Clerici G, Clerissi J, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients[J]. Eur J Vasc Endovasc Surg, 2006, 32(5): 484-490.
|
[13] |
庄金满,李选,李天润, 等. 股浅动脉重建对下肢动脉硬化闭塞症治疗的随机病例对照研究[J]. 北京大学学报(医学版), 2017, 49(1): 153-157.
|
[14] |
Tewksbury R, Pearch B, Redmond K, et al. Outcomes of infrapopliteal endoluminal intervention for transatlantic intersociety consensus C and D lesions in patients with critical limb ischaemia[J]. ANZ J Surg, 2014, 84(11): 866-870.
|
[15] |
Lee MS, Rha SW, Han SK, et al. Comparison of diabetic and non-diabetic patients undergoing endovascular revascularization for peripheral arterial disease[J]. J Invasive Cardiol, 2015, 27(3): 167-171.
|
[16] |
Dyet JF, Nicholson AA, Ettles DF. Vascular imaging and intervention in peripheral arteries in the diabetic patient[J]. Diabetes Metab Res Rev, 2000, 16(Suppl 1): S16-S22.
|
[17] |
Darling JD, McCallum JC, Soden PA, et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia[J]. J Vasc Surg, 2016, 64(3): 616-622.
|